F0761

E

Failure to Label and Discard Insulin and Ophthalmic/Otic Medications per Policy

Chrisman, Illinois Survey Completed on 01-14-2026

Penalty

No penalty information released

Summary

Surveyors identified a failure to properly label and discard medications during an inspection of the main skilled medication cart on the 200 Hall. In the presence of an LPN, one resident’s Basaglar insulin pen and Adelong insulin pen were found without documented dates of opening, despite the resident having active physician orders and currently receiving both medications per the January 2026 MAR. Another resident’s Novolog FlexPen was labeled with an open date of November 26, 2025, while the January 2026 MAR showed an active order and current administration of Novolog. Additionally, one resident’s Ofloxacin ear drops and another resident’s Latanoprost eye drops were found without documented open dates; the MARs showed that the Ofloxacin order had a completion date of January 1, 2026, and that the Latanoprost order was active and currently being administered.

During interviews, the LPN acknowledged that the insulin pens and Latanoprost eye drops should have been labeled with open dates and agreed that the Novolog FlexPen with the November 26, 2025 open date and the Ofloxacin without an open date should have been discarded. The DON stated that eye and ear drops are to be labeled with the date opened and discarded 28 days after opening, and that insulin vials and pens are to be labeled with the date opened and discarded within 28–30 days of opening. The facility’s Medication Labels Policy dated October 27, 2014, requires medications to be labeled in accordance with facility requirements and applicable laws, specifies that only the dispensing pharmacy or a registered pharmacist may modify or attach prescription labels, and requires every medication to be labeled with a beyond-use (expiration) date on the package.